Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Promega Biotech AB

Closing information (x1000 NOK)

Closing information 2025/03 2024/03 2023/03
Turnover 121,800 Less Arrow 98,438 Less Arrow 88,258
Financial expenses 32 Less Arrow 0 Equal arrow 0
Earnings before taxes 9,896 More Arrow 13,495 Less Arrow 12,669
EBITDA 9,971 More Arrow 13,572 Less Arrow 12,833
Total assets 52,157 Less Arrow 37,395 More Arrow 42,915
Current assets 51,969 Less Arrow 37,238 More Arrow 42,698
Current liabilities 19,691 Less Arrow 13,675 Less Arrow 10,162
Equity capital 29,182 Less Arrow 20,651 More Arrow 30,065
- share capital 105 Less Arrow 102 Less Arrow 100
Employees (average) 10 Equal arrow 10 Equal arrow 10

Financial ratios

Fiscal year 2025/03 2024/03 2023/03
Solvency 56.0% Less Arrow 55.2% More Arrow 70.1%
Turnover per employee 12,180 Less Arrow 9,844 Less Arrow 8,826
Profit as a percentage of turnover 8.1% More Arrow 13.7% More Arrow 14.4%
Return on assets (ROA) 19.0% More Arrow 36.1% Less Arrow 29.5%
Current ratio 263.9% More Arrow 272.3% More Arrow 420.2%
Return on equity (ROE) 33.9% More Arrow 65.3% Less Arrow 42.1%
Change turnover 19,785 Less Arrow 9,258 Less Arrow 4,622
Change turnover % 19% Less Arrow 10% Less Arrow 6%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2025/03 2024/03 2023/03
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.